Navigation Links
Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011
Date:6/24/2011

ess release due to a number of risks and uncertainties, including the risk that the analysis mentioned in this press release may not be predictive; BYDUREON may not be approved by the FDA as soon as anticipated or at all; the companies' response to the FDA's complete response letter may not be submitted in a timely manner and/or the information provided in such response may not satisfy the FDA; the QT study mentioned in this press release may not produce the results we expect; the FDA may request additional information prior to approval; BYETTA and/or the approval of BYDUREON and the revenues generated from these products may be affected by competition; unexpected new data; safety and technical issues; clinical trials not being completed in a timely manner, not confirming previous results, not being predictive of real world use or not achieving the intended clinical endpoints; label expansion requests or NDA filings not receiving regulatory approval; the commercial launch of BYDUREON being delayed; or manufacturing and supply issues. The potential for BYETTA and/or BYDUREON may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical products including those inherent in the collaboration with and dependence upon Amylin, Lilly and/or Alkermes. These and additional risks and uncertainties are described more fully in Amylin's, Lilly's and Alkermes' most recent SEC filings including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Amylin, Lilly and Alkermes undertake no duty to update these forward-looking statements.

BYDUREON™ and BYETTA® are trademarks of Amylin Pharmaceuticals, Inc. All other marks are the marks of their respective owners.

P-LLY

(i)  Long QT Syndrome. Heart Rhythm Society. Availab
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S.
2. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
3. PRA Early Phase Leaders to Speak at Bioanalysis Forum
4. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
5. Reportlinker Adds Distributor Analysis of the Pharmaceutical Industry in Key SADC Countries
6. Post Hoc Analysis from RECOVER Study Examined Effects of Neupro® (Rotigotine Transdermal System) on Surrogate Markers of Mood and Anhedonia in Parkinsons Disease
7. ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies
8. Hip Resurfacing Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
9. Reportlinker Adds Hip Replacement Implants - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
10. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
11. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
(Date:6/29/2015)... SOUTH EASTON, Mass. , June 29, 2015 ... the "Company"), a leader in the development and ... sample preparation solutions to the worldwide life sciences ... of the Institute of Molecular Systems Biology, ETH ... the proteomic profiling and classification of prostate cancer ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... , CARLSBAD, Calif., Dec. 21 Isis Pharmaceuticals, Inc. (Nasdaq: ... $10 million payment from OncoGenex Pharmaceuticals, Inc. (Nasdaq: ... to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is ... has completed a successful Phase 2 program in patients with ...
... , , , STOCKHOLM, December ... raising 380 MSEK (approximately 36,MEUR). This will secure Karolinska Development,s ... "The significant interest in this share issue shows ... us to pursue our long term,investment strategy. I am also ...
Cached Medicine Technology:Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 2Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva 3Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR) 2
(Date:6/30/2015)... Falls Church, VA (PRWEB) , ... June 30, ... ... (APNA) 29th Annual Conference will be held October 28-31, 2015 at Disney’s Coronado ... days of continuing nursing education and networking. Each year, this premiere event for ...
(Date:6/30/2015)... ... ... This Fourth of July, Peacock Alley celebrates the American ideals that ... commitment to quality, honesty and love of friends and family. These are the values ... of quilts, Peacock Alley was fully realized and grown while raising her family. Today, ...
(Date:6/29/2015)... ... June 30, 2015 , ... Sublime Beauty NATURALS® introduces its new USDA Certified ... ideal for natural skincare and even culinary uses, was especially designed for Oil Pulling. ... desire, and Oil Pulling can accomplish this. Oil Pulling is an Ayurvedic practice that ...
(Date:6/29/2015)... ... 2015 , ... With thousands of children in Utah Valley diagnosed on the ... center, planned at Utah Valley University, in Orem, Utah. The University has begun ... building in which it will be housed. , Utah Valley has the highest rate ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, one of ... John A. Mitamura, MD., PhD into their world-class multidisciplinary team of physicians and ... Long Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic surgeons of ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:New Product: Transform Wellness and Oral Health With This Ancient Ayurvedic Secret and Organic Product from Sublime Beauty NATURALS® 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 2Health News:doTERRA Partners With Utah Valley University on Autism Support Center 3Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3
... being introduced in the health care system to make doctors more ... for Health, Mary Harney said that the proposal includes various action ... Council to 7 out of a total of 25 members. Various ... common man to initiate inquiries into the behavior of doctors. ...
... which covers everything from checkups, prescription drugs and X-rays ... unanimously// by the San Francisco Board of Supervisors. ... plans which offer adults to gain access to medical ... The plan is financially backed by the local government, ...
... issued an apology after a diabetic man who suffered a ... leg with a misdiagnosis of gangrene.// Derek Atkinson, 56, from ... a consultant at Bishop Auckland General Hospital. ,In ... bottle and since the symptoms seemed very much like the ...
... Nadu and Maharashtra are to meet in Bangalore next month ... The disease has ravaged the four states and has infected ... to India through Kolkata in 1954-55. ,Andhra Pradesh ... to send in a representative at the meeting. Chikungunya was ...
... are increasing exponentially in over-50s in Scotland causing widespread ... transmitted diseases had more than trebled in this segment ... herpes are also rising rapidly in senior citizens in ... the safe sex message. ,The rise in ...
... Researchers at Dana-Farber Cancer Institute and Children's Hospital Boston ... that cause leukemia in a mouse model// of the ... isolated proved to be surprisingly different from normal blood ... news for developing a drug that selectively targets them. ...
Cached Medicine News:Health News:Scientists Isolate Leukemia Stem Cells in Mouse Model 2Health News:Scientists Isolate Leukemia Stem Cells in Mouse Model 3
For regulating sample flow rate when using the QIAvac 24 Plus;...
For processing mini spin columns on QIAvac 24;...
DNA/RNA preparation in 8-multi channels...
... Filter Units,Filter units with hydrophobic PTFE ... membrane are ideal for the sterilizing ... sterile containers, and for sterilizing or ... mm Millex filter units are available ...
Medicine Products: